Physician profile
Christopher J Hanssen
NPI 1528030467
$4,636.49
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $91.96 · 2021: $2,165 · 2022: $565 · 2023: $1,246 · 2024: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,613.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,347.84 | 2021 | |
| Stryker Corporation | $1,009.63 | 2019-2024 | Variax, Augment Injectable, Gamma |
| Pylant Medical | $747.55 | 2021-2023 | |
| Heron Therapeutics, INC. | $472.72 | 2023 | Zynrelef |
| Depuy Synthes Sales INC. | $453.38 | 2019-2024 | Motoband, Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $162.05 | 2020-2021 | |
| Vericel Corporation | $146.25 | 2023-2024 | Maci |
| Integra Lifesciences Corporation | $76.67 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Si-Bone, INC. | $51.73 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.25 | 2022-2023 | Seglentis |
| Davol INC. | $24.20 | 2022 | |
| Smith+Nephew, INC. | $24.14 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $23.75 | 2024 | Caldolor |
| Pacira Pharmaceuticals Incorporated | $20.13 | 2023 | Exparel |
| Cpm Medical Consultants, LLC | $20.08 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $14.17 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Moximed, INC | $11.95 | 2023 | Misha Knee System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hanssen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.